GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Deferred Tax

Sun Pharmaceuticals Industries (BOM:524715) Deferred Tax : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Sun Pharmaceuticals Industries's change in deferred tax for the three months ended in Mar. 2025 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Sun Pharmaceuticals Industries Deferred Tax Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Deferred Tax Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sun Pharmaceuticals Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sun Pharmaceuticals Industries Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries Deferred Tax Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Deferred Tax
Comparable Companies
NSE:DIVISLAB BOM:500087 NSE:TORNTPHARM BOM:500124 BOM:543904 BOM:532321 BOM:500257 NSE:AUROPHARMA BOM:500488 NSE:ALKEM ZTS XTER:MRK LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ HKSE:03692 XTAE:TEVA SHSE:688506 SZSE:000538
Traded in Other Exchanges
SUNPHARMA:India
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Website
https://www.sunpharma.com
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines